A team of researchers has now discovered that a drug initially developed to treat type 2 diabetes has “significantly reversed memory loss” in early animal trials.
Past research has already confirmed that single agonist drugs developed for diabetes display neuroprotective effects in animal models, but this is the first time that a triple receptor drug has been studied for these effects. Professor Holscher sees clear promise in these results, and while more research needs to be done, this does point to a potential new treatment for those suffering from Alzheimer’s disease.
Perhaps an even more compelling outcome of this study is that it adds to a growing body of evidence that links diabetes to Alzheimer’s. Of course, not everyone who develops type 2 diabetes will go on to develop Alzheimer’s, but there is a possible causal link between impaired insulin signalling and increased amyloid plaque.
Original Article: https://newatlas.com/diabetes-alzheimers-drug-reduces-memory-loss/52789/